Iterum Therapeutics Ltd.
We are a pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally.
$14.00 - $16.00
Leerink Partners, RBC Capital Markets, Guggenheim Securities, Needham & Company
To view the prospectus for Iterum Therapeutics Ltd. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277